Esperion Appoints Craig Thompson to Board of Directors
'We are thrilled to welcome Craig to our Board of Directors. With more than two decades of biopharmaceutical industry leadership and a proven track record advancing innovative therapies, Craig brings a wealth of strategic insight and operational expertise that will be invaluable as we continue to expand our impact in cardiovascular and cardiometabolic drug development. His deep understanding of pharmaceutical commercialization and clinical development aligns perfectly with our mission to deliver life-saving solutions to patients worldwide. We look forward to his contributions as we enter our next phase of growth and innovation,' stated Sheldon Koenig, President and CEO of Esperion.
"I am honored to join the Board of Esperion, a company at the forefront of transforming cardiovascular disease prevention. With cardiovascular conditions remaining the leading cause of death globally, the need for innovative, proactive solutions has never been greater. I look forward to working alongside this exceptional team to help guide strategic decisions and accelerate the development of impactful, science-driven approaches that can improve and extend lives," said Mr. Thompson.
Mr. Thompson has been the Chief Executive Officer and a member of the board of directors at Cerevance, a clinical stage biotechnology company focused on neurodegenerative, psychiatric, and CNS-controlled metabolic disorders, since April 2022. Mr. Thompson is also currently a member of the board of directors of NervGen Pharma Corp, a clinical stage biotechnology company focused on developing therapies for neurotrauma and neurologic diseases. Mr. Thompson was previously President & Chief Executive Officer and a member of the board of directors of Neurana Pharmaceuticals from June 2018 to April 2022. Prior to Neurana, Mr. Thompson was President & CEO of Anthera Pharmaceuticals Inc. Prior to Neurana, Mr. Thompson's biotechnology leadership experience included serving as Chief Operating Officer for Tetraphase Pharmaceuticals Inc. and as Chief Commercial Officer for Trius Therapeutics, Inc. where he was involved in the $700+ million acquisition of Trius Therapeutics by Cubist Pharmaceuticals, Inc., and led a partnership with Bayer Pharma AG.
Before that, Mr. Thompson served in various global and U.S. leadership roles at Pfizer Inc., including Therapeutic Group Leader of Allergy, Respiratory, Pulmonary Vascular Disease and Inflammation; and he ultimately served as Vice President of Marketing for Pfizer's Specialty Care Business Unit.
Previous to Pfizer, Mr. Thompson served in positions of increasing responsibility in global marketing at Merck & Co., where he was in product management for Zocor ®, including leading the rollout of the landmark Heart Protection Study. He also was instrumental in the pre-launch planning for Vytorin ® and Zetia ® as part of the European partnership between Merck and Schering-Plough.
Mr. Thompson holds a Bachelor of Commerce degree from McMaster University and an MBA from the University of Notre Dame.
About Esperion Therapeutics
Esperion Therapeutics, Inc. is a commercial stage biopharmaceutical company focused on bringing new medicines to market that address unmet needs of patients and healthcare professionals. The Company developed and is commercializing the only U.S. Food and Drug Administration (FDA) approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease and are struggling with elevated low density lipoprotein cholesterol (LDL-C). These medications are supported by the nearly 14,000 patient CLEAR Cardiovascular Outcomes Trial. Esperion continues to build on its success with its next generation program which is focused on developing ATP citrate lyase inhibitors (ACLYi). New insights into the structure and function of ACLYi fully enables rational drug design and the opportunity to develop highly potent and specific inhibitors with allosteric mechanisms.
Esperion continues to evolve into a leading global biopharmaceutical company through commercial execution, international partnerships and collaborations and advancement of its pre-clinical pipeline. For more information, visit esperion.com and follow Esperion on LinkedIn and X.
Forward-Looking Statements
This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the federal securities laws, including statements regarding marketing strategy and commercialization plans, current and planned operational expenses, future operations, commercial products, clinical development, including the timing, designs and plans for the CLEAR Outcomes study and its results, plans for potential future product candidates, financial condition and outlook, including expected cash runway, and other statements containing the words 'anticipate,' 'believe,' 'estimate,' 'expect,' 'intend,' 'may,' 'plan,' 'predict,' 'project,' 'suggest,' 'target,' 'potential,' 'will,' 'would,' 'could,' 'should,' 'continue,' and similar expressions. Any express or implied statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause Esperion's actual results to differ significantly from those projected, including, without limitation, the net sales, profitability, and growth of Esperion's commercial products, clinical activities and results, supply chain, commercial development and launch plans, the outcomes and anticipated benefits of legal proceedings and settlements, and the risks detailed in Esperion's filings with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and Esperion disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release, other than to the extent required by law.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
8 minutes ago
- Globe and Mail
Centene Corporation (CNC) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before September 8, 2025
New York, New York--(Newsfile Corp. - August 20, 2025) - If you suffered a loss on your Centene Corporation (NYSE: CNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: or contact Joseph E. Levi, Esq. via email at jlevi@ or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against Centene Corporation that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between December 12, 2024 and June 30, 2025. CASE DETAILS: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Centene's enrollment and morbidity rates. Investors began to question the veracity of defendants' public statements on July 1, 2025, when Centene issued a press release withdrawing 2025 guidance. Particularly, following an analysis of the 2025 Health Insurance Marketplace, Centene's overall market growth across 22 states, or 72% of the Company's marketplace membership, was lower than expected. In pertinent part, the Company stated that this preliminary analysis resulted in a reduction of its previously issued guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75. Following this news, Centene's common stock declined dramatically, from a closing market price of $56.65 per share on July 1, 2025, Centene's stock price fell to $33.78 per share on July 2, 2025, a decline of 40.4%. WHAT'S NEXT? If you suffered a loss in Centene stock during the relevant time frame - even if you still hold your shares - go to to learn about your rights to seek a recovery. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
Globe and Mail
8 minutes ago
- Globe and Mail
TheBuzzBlast Cracks the Code on Search Engine Visibility for Small Business Websites: From Page 10 to Page 1 Through Strategic Media Authority
"In today's digital economy, media credibility isn't just about prestige – it's the difference between being invisible online and becoming the trusted choice customers seek out. TheBuzzBlast has democratized access to this credibility, proving that every business, regardless of size or budget, deserves the authority that comes from major media recognition." Revolutionary PR Platform Helps Small Businesses Bypass Years of SEO Struggle by Building Instant Search Engine Authority Through High-Impact Media Placements NEW YORK, NY - August 20, 2025 - In a breakthrough that's reshaping how small business websites achieve search engine visibility, TheBuzzBlast has developed a proven methodology that catapults unknown websites from search engine obscurity to prominent rankings through strategic media placement and authority building. The innovative platform at is demonstrating that small businesses no longer need expensive SEO agencies or years of content creation to appear in Google, Bing, and Yahoo search results – they need the right media credibility signals that search engines recognize and reward, starting from just $77. With Google processing over 8.5 billion searches daily and 75% of users never scrolling past the first page of results, small business websites face an almost impossible challenge: competing against established sites with years of domain authority. The Buzz Blast PR has revolutionized this dynamic by leveraging a fundamental truth about search engine algorithms: they prioritize websites mentioned in authoritative media sources. When small business websites gain media coverage through the platform, search engines immediately recognize them as credible sources worth ranking. "Search engines are essentially trust-sorting machines, and nothing signals trust faster than media coverage," explains the platform's search optimization team. "We've watched hundreds of small business websites go from completely invisible in search results to ranking on page one within weeks of their media placements going live. doesn't replace SEO – it accelerates it by years, giving small businesses the authority signals that typically take a decade to build organically." The impact on search engine visibility is both immediate and compounding. Small business websites using The Buzz Blast PR report average improvements including: 400% increase in organic search traffic within 60 days, jumping from page 5+ to page 1 for their primary keywords, appearance in Google's "Top Stories" and news sections, increased crawl frequency as search engines recognize new authority, and perhaps most importantly, ranking for competitive keywords previously dominated by industry giants. These aren't theoretical benefits – they're measurable results tracked across thousands of small business campaigns. What makes particularly powerful for search engine optimization is how media placements create multiple ranking signals simultaneously. Each media feature generates high-authority backlinks that search engines value above almost all other ranking factors. The increased brand mentions across the web trigger Google's entity recognition systems. Fresh, relevant content about the business appears on trusted domains. Social signals multiply as media coverage gets shared. The cumulative effect is a massive authority boost that would typically require hundreds of thousands of dollars in traditional SEO investment. The platform's approach solves a critical problem plaguing small business websites: the vicious cycle of no visibility leading to no traffic, which leads to continued invisibility. Traditional SEO wisdom suggests patient content creation and gradual link building over years. But has proven that strategic media placement can break this cycle in days, not decades. Small businesses report going from zero organic traffic to thousands of monthly visitors, all traceable to the authority boost from media coverage. Real-world results from small business clients illuminate the transformation. A local bakery website that hadn't appeared in search results for "bakery near me" suddenly ranked third after media placement. A consultant's website jumped from page eight to page two for competitive industry terms within two weeks. An online boutique started appearing in Google Shopping results after previously being invisible. These dramatic improvements occur because search engines interpret media coverage as powerful validation that these businesses deserve visibility. The timing of this breakthrough couldn't be more critical for small businesses. With Google's helpful content updates and emphasis on E-A-T (Expertise, Authoritativeness, Trustworthiness), small business websites without established authority are finding it increasingly difficult to rank. The Buzz Blast PR provides the exact signals Google is looking for: third-party validation from recognized media sources that establish expertise and trustworthiness instantly. This isn't about gaming the algorithm – it's about providing search engines with legitimate credibility indicators they're designed to recognize and reward. Industry SEO experts analyzing TheBuzzBlast's impact note that the platform has essentially democratized search engine authority. Previously, only large corporations with massive PR budgets could secure the media coverage necessary to dominate search results. Now, small business websites can achieve similar authority signals for less than the cost of a monthly SEO tool subscription. This levels the playing field in ways that traditional SEO services simply cannot match. The platform's success in driving search engine visibility extends beyond just rankings. Small businesses report that their enhanced search presence leads to improved click-through rates (users trust results with media credibility), lower bounce rates (visitors stay longer on credible sites), and higher conversion rates (search traffic arrives pre-qualified based on media authority). The compound effect transforms search engine visibility from a distant dream into immediate reality. For the millions of small business websites languishing in search engine obscurity, watching competitors dominate while they remain invisible, represents a fundamental shift in how search visibility is achieved. Instead of the slow, uncertain path of traditional SEO, small businesses now have access to a proven shortcut that delivers the authority signals search engines crave. The message is clear: in today's search landscape, media credibility isn't just helpful for SEO – it's the fastest path from search engine invisibility to prominence that small businesses have ever had access to. About TheBuzzBlast TheBuzzBlast is the leading PR platform for small business search engine optimization, helping websites achieve dramatic improvements in Google, Bing, and Yahoo rankings through strategic media placement and authority building. Starting from just $77, the platform has helped thousands of small business websites escape search engine obscurity and achieve page-one rankings through proven media credibility strategies. Media Contact: TheBuzzBlast PR Team Website: Email: Contact via website
CBC
8 minutes ago
- CBC
U.S. orange juice shipments plummet as Canadians find Florida OJ hard to swallow
Feeling a little squeezed in the orange juice aisle? Between the climbing cost for a carton of fresh-squeezed juice, steep counter-tariffs on U.S. juices like Tropicana, and now plummeting U.S. shipments, you might worry this breakfast staple is in danger of becoming a luxury good. But industry and business experts say none of this is unexpected and that consumers have options. Canada is seeing a "dramatic reduction" in imports of orange juice from Florida but that is to be expected, given the rising prices and the fact that the beverage was specifically targeted by our counter-tariffs, said Michael von Massow, a professor of food agriculture and resource economics at the University of Guelph in Ontario. In other words, the marked drop in imports has been compounded by the ongoing consumer desire to buy Canadian, he said. "We are probably seeing an effect here where just the American product is going up in price — which means that it's going down in demand — but there are other options on the shelf," von Massow told CBC News. "Unless you're tied specifically to fresh-pressed orange juice from Florida." WATCH | Orange juice prices hard to swallow? You have options: High price of Florida OJ hard to swallow? You have options 4 hours ago If you've stopped buying orange juice from Florida because the tariffs have sent prices soaring, there are many options to keep the breakfast staple on your table, says Michael von Massow of the University of Guelph. U.S. shipments drop to 20-year low The total value of U.S. shipments of fresh orange juice to Canada saw a steep drop in June to its lowest level in more than 20 years, according to data from both the U.S. Census Bureau and Statistics Canada. The total import value in June of fresh orange juice from the U.S. into Canada was $5.78 million, compared to nearly $12 million in June 2024, according to Statistics Canada. Since January alone, the monthly import value dropped by 64 per cent. There are a number of factors at play, said William Huggins, an assistant professor of finance and business economics at McMaster University in Hamilton. Supply constraints push up prices, which reduces demand, he said. Plus, there are the 25 per cent counter-tariffs imposed by Canada on March 4. Canada's response to U.S. President Donald Trump's tariffs affects $30 billion worth of U.S. goods, including orange juice. "Canada specifically targeted Florida orange juice as a way of making a political point. We weren't even shy about it," Huggins said. Orange juice is practically symbolic of the U.S., much in the same way that maple syrup is for Canada, he explained. It's also become emblematic of the consumer boycott, he added: when shoppers think of orange juice, they think of Florida, and when they think of Florida, they think of Trump and his Mar a Lago home. "The most basic thing you can do to give your finger to the most powerful man in the world is to hurt his home state's economy," Huggins said. Prices on the way up Orange juice prices have always been volatile, as The Associated Press notes. Prices fall when bumper harvests create an oversupply of oranges and rise when frost or a hurricane knocks out fruit trees. And recently, the price has been going up, according to Statistics Canada. The monthly average retail price for a two-litre carton shot up in June to $5.95, from $5.62 in January, and is up 54 per cent compared to June 2020. This year's harvest in Brazil, the world's largest exporter of orange juice, is likely to be the worst in 36 years due to flooding and drought, according to a forecast by Fundecitrus, a citrus growers' organization in Sao Paulo state. In the U.S., Florida's already diminished orange production fell 62 per cent in the 2022-23 season after Hurricane Ian battered a crop that was already struggling due to an invasive pest. Drought also cut Spain's orange production last year. But what Statistics Canada doesn't show is that the price increase here is largely driven by the price of Florida orange juice, von Massow reiterated. At Loblaws, for example, a 2.63-litre container of U.S.-based Tropicana might cost up to $13.50 but the prepared-in-Canada PC brand currently costs $6.50. At Metro, 2.63 litres of Tropicana orange juice is $13.99, but 2.5 litres of Irresistible brand is $7.69. Canadian-owned juice brand Oasis, which sources its oranges from Brazil and bottles the juice in Quebec, costs $5.49 for 1.5 litres at Food Basics. But all these prices are significantly higher than what Canadians paid in 2017. According to Statistics Canada, a two-litre container of orange juice back then cost about $3.61— 40 per cent less than what it costs now. Price increases turning off consumers And consumers aren't buying it. Global orange juice demand dropped 15 per cent year-over-year between 2025 and 2024, according to a May report from Rabobank, a Dutch bank that focuses on food and agriculture. They cited high prices, weaker consumer sentiment and limited availability. In a July report, Rabobank noted a "sharp decline in global orange juice supply." Some Canadian businesses have told CBC they've stopped serving orange juice as they rethink their relationship with U.S. products. Huggins said he really doesn't foresee orange juice becoming the next "liquid gold," like olive oil, which recently saw its price double over three years. Consumers have other options, he explained, and the boycott sentiment is still going strong. "It's not like there are no substitutes for orange juice. People will just drink apple juice," Huggins said. B & B swaps out orange juice for local apple cider amid tariffs 7 months ago Carol Ann McDevitt, who owns the Roaring 20s Bed and Breakfast, about 40 kilometres west of Fredericton, is putting apple cider on the menu in place of imported U.S orange juice. And it's not because of the cost.
